Mymetics Corp (MYMX)

[Work Harder]

Astellas Pharma & Immunomic Therapeutics Announce $300-Million Worldwide Partnership for LAMP-vax Products

Upon execution of the new agreement, Immunomic Therapeutics will receive an upfront payment of $300 million and be entitled to receive 10% royalties of net sales of the potential products.

https://drug-dev.com/astellas-pharma-immunomic-therapeutics-announce-300-million-worldwide-partnership-for-lamp-vax-products/

ASP0892 is designed to generate a Th1–mediated immune response

https://www.immunomix.com/pipeline/allergy/

DNA VACCINE TECHNOLOGY – A Vaccine Breakthrough That Could Change Lives & Enable Vaccine Development Programs

https://drug-dev.com/dna-vaccine-technology-a-vaccine-breakthrough-that-could-change-lives-enable-vaccine-development-programs/

https://adisinsight.springer.com/drugs/800037023